Doo Hyun Chung

Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib

Sae‐Won Han, Tae‐You Kim, Pil Gyu Hwang et al. · Journal of Clinical Oncology · 2005 · 775 citations · Full text

Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas

Jake June-Koo Lee, Junehawk Lee, Sehui Kim et al. · Journal of Clinical Oncology · 2017 · 498 citations

Pathology, Purpose Histologic Transformation, Genetic Predictors +20

STAT3 is a potential modulator of HIF‐1‐mediated VEGF expression in human renal carcinoma cells

Joo Eun Jung, H. S. Lee, Ik‐Hyun Cho et al. · The FASEB Journal · 2005 · 428 citations

Hif‐1‐mediated Vegf Expression, Cancer Biology, Tumor Biology +18

Pan-Cancer Immunogenomic Perspective on the Tumor Microenvironment Based on PD-L1 and CD8 T-Cell Infiltration

Chan-Young Ock, Bhumsuk Keam, Sehui Kim et al. · Clinical Cancer Research · 2016 · 285 citations

Optimization of Patient Selection for Gefitinib in Non–Small Cell Lung Cancer by Combined Analysis of Epidermal Growth Factor Receptor Mutation, K-ras Mutation, and Akt Phosphorylation

Sae‐Won Han, Tae‐You Kim, Yoon Kyung Jeon et al. · Clinical Cancer Research · 2006 · 256 citations · Full text